Google Ventures Biotech Portfolio 2026

4 Biotech companies backed by Google Ventures, including Leyden Labs, Merida Biosciences, Rhygaze — with the co-investors on each cap table.

Google Ventures — Biotech accounts for 4 tracked companies with verified cap-table data, 4 of which disclose round sizes totalling $660M. The median disclosed raise is $202M, and the largest is Cerevance at $204M, ahead of Rani Therapeutics ($202M) and Pelage Pharmaceuticals ($154M).

The names that recur most often on these portfolio cap tables are Google Ventures (4 companies), Bill Gates (1 company), Casdin Capital (1 company), Lightstone Ventures (1 company), Foresite Capital (1 company), UPMC Enterprises (1 company). By latest disclosed round, the market skews Series B (2), Growth (1), Series A (1).

Best funded Google Ventures — Biotech companies

  1. Cerevance — $204M (latest: Series B)
  2. Rani Therapeutics — $202M (latest: Growth)
  3. Pelage Pharmaceuticals — $154M (latest: Series B)
  4. Vitara Biomedical — $100M (latest: Series A)

Google Ventures — related firms and companies (56)

Google Ventures alternatives · All research reports